Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Metabolic Brain Disease|August 16, 2016
Vegetarian diet and excessive tea consumption: a dangerous association?Fabrizio Fiacco, Luca Barbato, Maria Giovanna Pecoraro, et al.Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|September 10, 2013
Occult spinal dysraphism: lessons learned by retrospective analysis of 149 surgical cases about natural history, surgical indications, urodynamic testing, and intraoperative neurophysiological monitoringLaura Grazia Valentini, Giorgio Selvaggio, Alessandra Erbetta, et al.Lung Cancer (Amsterdam, Netherlands)|October 27, 2022
Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLCFabio Salomone, Fabrizio Di Costanzo, Giovanna Pecoraro, et al.Critical Reviews in Oncology/Hematology|September 26, 2024
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative reviewAnnarita Peddio, Erica Pietroluongo, Maria Rosaria Lamia, et al.Critical Reviews in Oncology/Hematology|November 29, 2024
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directionsAldo Caltavituro, Roberto Buonaiuto, Fabio Salomone, et al.Biomolecules|October 27, 2022
Insight on the Role of Leptin: A Bridge from Obesity to Breast CancerRoberto Buonaiuto, Fabiana Napolitano, Sara Parola, et al.International Journal of Molecular Sciences|June 13, 2025
Integrating Aggressive-Variant Prostate Cancer-Associated Tumor Suppressor Gene Status with Clinical Variables to Refine Prognosis and Predict Androgen Receptor Pathway Inhibitor Response in Metastatic Hormone-Sensitive SettingMartino Pedrani, Giuseppe Salfi, Sara Merler, et al.Cancers|December 11, 2025
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early VariationsGiuseppe Salfi, Martino Pedrani, Amos Colombo, et al.Cancers|December 9, 2023
Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary TumorsFabrizio Di Costanzo, Fabiana Napolitano, Fabio Salomone, et al.Drugs|July 29, 2026
DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future PerspectivesGiovanna Pecoraro, Alberto De Giorgi, Giulia Montelatici, et al.Pageof 2